A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.

• Phase: Phase 2

Details

• Lead Sponsor: Kissei Pharmaceutical Co., Ltd.
• Treatments: Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Corneal and conjunctival damage

• Insufficiency of lacrimal secretion

• Ocular symptom

Exclusion Criteria:

• Severe ophthalmic disorder

• Punctual plugs or surgery for occlusion of the lacrimal puncta